v3.25.2
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenues:        
Revenue from collaborative arrangement $ 0 $ 100,762 $ 65,343 $ 100,762
Operating expenses:        
Research and development 14,521,407 23,090,989 30,612,309 44,001,307
General and administrative 8,563,112 10,206,686 17,588,082 20,781,337
Total operating expenses 23,084,519 33,297,675 48,200,391 64,782,644
Loss from operations (23,084,519) (33,196,913) (48,135,048) (64,681,882)
Other income (expense):        
Interest income 610,638 1,307,358 1,418,715 2,807,648
Interest expense 0 0 0 (177,833)
Change in fair value of common stock warrant liability (1,878,010) 0 1,834,862 0
Gain (loss) on investment in affiliated entity 776,373 (334,294) 1,471,504 (460,312)
Net unrealized gain (loss) on available-for-sale equity securities 759,289 (20,820) 899,523 480,057
Other (expense) income, net (703,183) 7,571 (703,665) (674,647)
Net loss $ (23,519,412) $ (32,237,098) $ (43,214,109) $ (62,706,969)
Net loss per share        
Basic (in dollars per share) $ (0.61) $ (1.19) $ (1.12) $ (2.48)
Diluted (in dollars per share) $ (0.61) $ (1.19) $ (1.12) $ (2.48)
Weighted average number of common shares used to compute net loss per share        
Basic (in shares) 38,830,053 27,197,802 38,722,451 25,244,657
Diluted (in shares) 38,830,053 27,197,802 38,722,451 25,244,657